Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

REXR REXFORD INDUSTRIAL REALTY, INC.
$37.27 -0.01% -0.01
Notify me if price changes either direction
Interactive Brokers Logotype

Buy REXR stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 8.5B
Enterprise value 12.1B
Trailing PE 39.537636
Forward PE 38.17138
PEG Ratio -0.069263011970803
Enterprise to EBITDA 17.886
Enterprise to revenue 12.212
Price to book MRQ 1.1348447
Price to sales TTM 8.688554

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 991.9M
EBITDA 630.5M
Diluted EPS TTM -1.78
Total Cash (MRQ) 41.5M
Current ratio (MRQ) 0.344
Operating Cash Flow (TTM) 509.3M

REXR trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent REXR News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.